Related Experiment Video
Updated: Aug 18, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
Improving cardiovascular health outcomes through the use of evidence-based medicine
1Case Western Reserve University School of Medicine, 10900 Euclid Ave, Cleveland, Ohio, USA. baltimore@ameritech.net
Insights
Cardiovascular and renal risks increase with low blood pressure (BP), often linked to metabolic syndrome. Rapid BP control is key to reducing stroke events, while certain medications may lower type 2 diabetes risk.
Area of Science:
- Cardiology
- Nephrology
- Endocrinology
Background:
- Cardiovascular (CV) and renal complications risk starts at low blood pressure (BP).
- Metabolic syndrome is associated with increased CV and renal risk.
- Older and newer antihypertensive agents show similar CV event rates.
Purpose of the Study:
- To evaluate the impact of blood pressure control on cardiovascular and renal outcomes.
- To compare the efficacy of different antihypertensive agents.
- To assess the effect of specific drug classes on type 2 diabetes onset.
Main Methods:
- Comparative analysis of antihypertensive agents.
- Focus on blood pressure management strategies.
- Longitudinal tracking of cardiovascular, renal, and diabetes-related events.
Main Results:
- Rapid blood pressure control significantly reduces event rates, especially stroke.
- No major differences in CV event rates between older and newer antihypertensive agents.
- Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers show a consistent reduction in type 2 diabetes onset.
Conclusions:
- Aggressive blood pressure management is crucial for preventing cardiovascular and renal complications.
- Certain antihypertensive drug classes offer additional benefits in preventing type 2 diabetes.
- Further research into optimal BP targets and agent selection is warranted.
Abstract:
The risk of cardiovascular (CV) and renal complications begins at a relatively low blood pressure (BP), and this risk is associated with such disorders as metabolic syndrome. When comparing older antihypertensive agents with newer agents, for the most part no significant differences have been seen in rates of CV events. However, rapidly controlling BP is critical to reduce event rates, particularly rates of stroke. Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers consistently decrease the rate of onset of type 2 diabetes.
Related Concept Videos
Atherosclerosis III: Management
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Exercise and Cardiac Output
Sustained exercise increases the muscles' oxygen demand, which can be met...
Cardiomyopathy V: Interprofessional Care
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease IV: Preventive Measures
